These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

247 related items for PubMed ID: 1549846

  • 1. The significance of the anti-class I response. II. Clinical and pathologic features of renal transplants with anti-class I-like antibody.
    Halloran PF, Schlaut J, Solez K, Srinivasa NS.
    Transplantation; 1992 Mar; 53(3):550-5. PubMed ID: 1549846
    [Abstract] [Full Text] [Related]

  • 2. Donor-specific antibodies against HLA, MICA, and GSTT1 in patients with allograft rejection and C4d deposition in renal biopsies.
    Alvarez-Márquez A, Aguilera I, Gentil MA, Caro JL, Bernal G, Fernández Alonso J, Acevedo MJ, Cabello V, Wichmann I, Gonzalez-Escribano MF, Núñez-Roldán A.
    Transplantation; 2009 Jan 15; 87(1):94-9. PubMed ID: 19136897
    [Abstract] [Full Text] [Related]

  • 3. Detection and analysis of HLA class I and class II specific alloantibodies in the sera of dialysis recipients waiting for a renal retransplantation.
    Barocci S, Valente U, Nocera A.
    Clin Transplant; 2007 Jan 15; 21(1):47-56. PubMed ID: 17302591
    [Abstract] [Full Text] [Related]

  • 4. Reappraisal of HLA antibody analysis and crossmatching in kidney transplantation.
    Lee PC, Ozawa M.
    Clin Transpl; 2007 Jan 15; ():219-26. PubMed ID: 18642453
    [Abstract] [Full Text] [Related]

  • 5. Clinical relevance of low levels of preformed alloantibodies detected by flow cytometry in the first year post-kidney transplantation.
    Michelon T, Schroeder R, Fagundes I, Canabarro R, Sporleder H, Rodrigues H, Silveira J, Montagner J, Garcia V, Neumann J, Graudenz M.
    Transplant Proc; 2005 Jan 15; 37(6):2750-2. PubMed ID: 16182800
    [Abstract] [Full Text] [Related]

  • 6. Post transplant development of MICA and anti-HLA antibodies is associated with acute rejection episodes and renal allograft loss.
    Panigrahi A, Gupta N, Siddiqui JA, Margoob A, Bhowmik D, Guleria S, Mehra NK.
    Hum Immunol; 2007 May 15; 68(5):362-7. PubMed ID: 17462503
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Clinical relevance of Luminex donor-specific crossmatches: data from 165 renal transplants.
    Billen EV, Christiaans MH, van den Berg-Loonen EM.
    Tissue Antigens; 2009 Sep 15; 74(3):205-12. PubMed ID: 19497037
    [Abstract] [Full Text] [Related]

  • 9. Antibodies against MICA antigens and kidney-transplant rejection.
    Zou Y, Stastny P, Süsal C, Döhler B, Opelz G.
    N Engl J Med; 2007 Sep 27; 357(13):1293-300. PubMed ID: 17898098
    [Abstract] [Full Text] [Related]

  • 10. Value of donor-specific antibody detection in first-graft renal transplant recipients with a negative complement-dependent cytotoxic crossmatch.
    Mahmoud KM, Ismail AM, Sheashaa HA, Gheith OA, Kamal MM, Ghoneim MA.
    Exp Clin Transplant; 2009 Jun 27; 7(2):124-8. PubMed ID: 19715518
    [Abstract] [Full Text] [Related]

  • 11. Anti-glutathione S-transferase T1 antibody-mediated rejection in C4d-positive renal allograft recipients.
    Aguilera I, Alvarez-Marquez A, Gentil MA, Fernandez-Alonso J, Fijo J, Saez C, Wichmann I, Nuñez-Roldan A.
    Nephrol Dial Transplant; 2008 Jul 27; 23(7):2393-8. PubMed ID: 18308775
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Induction of chronic renal allograft injury by injection of a monoclonal antibody against a donor MHC Ib molecule in a nude rat model.
    Koch M, Broecker V, Heratizadeh A, Doege C, Strehlau J, Mengel M, Nashan B.
    Transpl Immunol; 2008 Jul 27; 19(3-4):187-91. PubMed ID: 18595711
    [Abstract] [Full Text] [Related]

  • 14. Prevalence and significance of anti-HLA and donor-specific antibodies long-term after renal transplantation.
    Cardarelli F, Pascual M, Tolkoff-Rubin N, Delmonico FL, Wong W, Schoenfeld DA, Zhang H, Cosimi AB, Saidman SL.
    Transpl Int; 2005 May 27; 18(5):532-40. PubMed ID: 15819801
    [Abstract] [Full Text] [Related]

  • 15. Absence of irreversible rejection in the presence of warm anti-donor-HLA class I cytotoxic IgG antibody.
    Shoker A, Klassen J, Herbut B.
    Clin Nephrol; 1997 Feb 27; 47(2):87-91. PubMed ID: 9049455
    [Abstract] [Full Text] [Related]

  • 16. Transplant glomerulopathy: risk and prognosis related to anti-human leukocyte antigen class II antibody levels.
    Issa N, Cosio FG, Gloor JM, Sethi S, Dean PG, Moore SB, DeGoey S, Stegall MD.
    Transplantation; 2008 Sep 15; 86(5):681-5. PubMed ID: 18791449
    [Abstract] [Full Text] [Related]

  • 17. Association of kidney transplant failure and antibodies against MICA.
    Mizutani K, Terasaki P, Bignon JD, Hourmant M, Cesbron-Gautier A, Shih RN, Pei R, Lee J, Ozawa M.
    Hum Immunol; 2006 Sep 15; 67(9):683-91. PubMed ID: 17002898
    [Abstract] [Full Text] [Related]

  • 18. Posttransplantation production of donor HLA-specific antibodies as a predictor of renal transplant outcome.
    Worthington JE, Martin S, Al-Husseini DM, Dyer PA, Johnson RW.
    Transplantation; 2003 Apr 15; 75(7):1034-40. PubMed ID: 12698094
    [Abstract] [Full Text] [Related]

  • 19. Alloantibodies and the outcome of cadaver kidney allografts.
    Vasilescu ER, Ho EK, Colovai AI, Vlad G, Foca-Rodi A, Markowitz GS, D'Agati V, Hardy MA, Ratner LE, Suciu-Foca N.
    Hum Immunol; 2006 Aug 15; 67(8):597-604. PubMed ID: 16916655
    [Abstract] [Full Text] [Related]

  • 20. IgG donor-specific crossmatches are not associated with graft rejection or poor graft survival after liver transplantation. An assessment by cytotoxicity and flow cytometry.
    Donaldson PT, Thomson LJ, Heads A, Underhill JA, Vaughan RW, Rolando N, Williams R.
    Transplantation; 1995 Nov 15; 60(9):1016-23. PubMed ID: 7491675
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 13.